The results herein suggest that AQP4 polymorphisms play a role in MS pathogenesis and responsiveness to rehabilitation, potentially by modulating astrocytic water homeostasis, BBB integrity, neuroinflammatory processes, and neuroplasticity, processes critically involved both in MS progression and in recovery mechanisms [6]. The gene discussed is AQP4; the disease is myeloid sarcoma.